Correlation Between Ascendis Pharma and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and Denali Therapeutics, you can compare the effects of market volatilities on Ascendis Pharma and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Denali Therapeutics.
Diversification Opportunities for Ascendis Pharma and Denali Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Ascendis and Denali is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Ascendis Pharma and Denali Therapeutics
Given the investment horizon of 90 days Ascendis Pharma AS is expected to under-perform the Denali Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ascendis Pharma AS is 2.2 times less risky than Denali Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Denali Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 2,084 in Denali Therapeutics on November 3, 2024 and sell it today you would earn a total of 246.00 from holding Denali Therapeutics or generate 11.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ascendis Pharma AS vs. Denali Therapeutics
Performance |
| Timeline |
| Ascendis Pharma AS |
| Denali Therapeutics |
Ascendis Pharma and Denali Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ascendis Pharma and Denali Therapeutics
The main advantage of trading using opposite Ascendis Pharma and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.| Ascendis Pharma vs. Apellis Pharmaceuticals | Ascendis Pharma vs. Akero Therapeutics | Ascendis Pharma vs. Blueprint Medicines Corp | Ascendis Pharma vs. Replimune Group |
| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |